Reference : Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoa...
Scientific journals : Letter to the editor
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/219991
Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
-
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Cooper, C. [MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom]
Bruyère, Olivier mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
2016
Current Medical Research and Opinion
Taylor and Francis Ltd
32
11
1771-1772
Yes (verified by ORBi)
International
0300-7995
1473-4877
[en] Letter
[en] [No abstract available]
http://hdl.handle.net/2268/219991
10.1080/03007995.2016.1239575

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Re. E.J. KUCHARZ, et al. A review of glucosamine for knee osteoarthritis. why patented crystalline glucosamine sulfate should be differentiated from the other glucosamines to .... Cur Med Res.pdfPublisher postprint448.79 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.